Connect Biopharma Holdings Limited (CNTB)
USD 0.98
(-5.23%)
USD 0.98
(-5.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -47.93 Million | -99.26 Million | -85.56 Million | -25.6 Million | -13.09 Million |
| Net Income | -59.38 Million | -116.11 Million | -204.93 Million | -119.36 Million | -24.46 Million |
| Depreciation & Amortization | 988 Thousand | 1.01 Million | 640.98 Thousand | 221.05 Thousand | 114.61 Thousand |
| Deferred income taxes | -272 Thousand | 3.36 Million | 106.36 Million | 89.67 Million | 8.3 Million |
| Stock-based compensation | 3.25 Million | 1 Million | 1.41 Million | 590.64 Thousand | 562.17 Thousand |
| Change in working capital | 9.48 Million | 7.16 Million | 3.26 Million | -436.28 Thousand | 2.38 Million |
| Other non-cash items | -2 Million | -1.35 Million | 6909.14 | 443.17 Thousand | 7689.09 |
| Investing Cash Flow | 75.15 Million | -83.44 Million | -5.34 Million | 449.15 Thousand | -484.7 Thousand |
| Investments in PPE | -294 Thousand | -4.28 Million | -7.46 Million | -2.34 Million | -155.52 Thousand |
| Acquisitions | 2.94 Million | 79.16 Thousand | 47.73 Thousand | 53.46 Thousand | 329.18 |
| Investment purchases | -32.6 Million | -113.7 Million | -17.97 Million | -16.33 Million | -23.64 Million |
| Sales/Maturities of investments | 105.19 Million | 34.54 Million | 20.09 Million | 19.12 Million | 23.31 Million |
| Other Investing Activities | -84 Thousand | -79.16 Thousand | -47.73 Thousand | -53.46 Thousand | -329.18 |
| Financing Cash Flow | -246 Thousand | -91.28 Thousand | 206.66 Million | 140.74 Million | -57.45 Thousand |
| Debt repayment | -290 Thousand | -221.27 Thousand | -126.4 Thousand | -82.41 Thousand | -64.55 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | -576.91 Thousand | - | - |
| Common Stock Issuance | 44 Thousand | 19.27 Thousand | 224.82 Million | - | - |
| Other Financing Activities | 44.00 | 110.71 Thousand | -17.42 Million | 140.82 Million | 7108.78 |
| Accounts receivables | 1.04 Million | 3371.57 | -2530.63 | -1432.33 | -439.00 |
| Accounts payables | -4.27 Million | 375.65 Thousand | 8.88 Million | 283.4 Thousand | 2.8 Million |
| Inventory | - | -3371.57 | 2530.63 | 1432.33 | 439.00 |
| Other working capital | 13.76 Million | 6.78 Million | -5.61 Million | -719.68 Thousand | -425.22 Thousand |
| Cash at beginning of period | 79.01 Million | 249.3 Million | 158.6 Million | 47.33 Million | 58.26 Million |
| Cash at end of period | 106 Million | 80.37 Million | 268.02 Million | 154.73 Million | 44.82 Million |
| Capital Expenditure | -294 Thousand | -4.28 Million | -7.46 Million | -2.34 Million | -155.52 Thousand |
| Effect of forex changes on cash | 18 Thousand | 13.87 Million | -6.33 Million | -8.18 Million | 198.46 Thousand |
| Net cash flow / Change in cash | 26.99 Million | -168.93 Million | 109.41 Million | 107.4 Million | -13.43 Million |
| Free Cash Flow | -48.22 Million | -103.55 Million | -93.03 Million | -27.95 Million | -13.24 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.82 Million | 3.82 Million | -14.8 Thousand | -59.38 Million | -15.22 Thousand | -30.58 Million |
| Depreciation & Amortization | 238 Thousand | 238 Thousand | 246.64 | 988 Thousand | 253.61 | 506.12 Thousand |
| Deferred income taxes | - | - | - | -272 Thousand | - | -1.45 Million |
| Stock-based compensation | 919.5 Thousand | 919.5 Thousand | 496.64 | 3.25 Million | 528.58 | 1107.13 |
| Change in working capital | 480 Thousand | 480 Thousand | 953.31 | 9.48 Million | 936.15 | -1.71 Million |
| Other non-cash items | -9.44 Million | -9.44 Million | 4337.13 | -2 Million | 4308.41 | 2.16 Million |
| Investing Cash Flow | 6.13 Million | 6.13 Million | 20.83 Thousand | 75.15 Million | 21.31 Thousand | 34.25 Million |
| Investments in PPE | -218 Thousand | -218 Thousand | -7.38 | -294 Thousand | -11.32 | -285.67 Thousand |
| Acquisitions | - | - | - | 2.94 Million | - | -16.49 Thousand |
| Investment purchases | - | - | - | -32.6 Million | - | -30.96 Million |
| Sales/Maturities of investments | 12.75 Million | - | - | 105.19 Million | - | 65.49 Million |
| Other Investing Activities | 6.35 Million | 6.35 Million | 20.84 Thousand | -84 Thousand | 21.32 Thousand | 16.49 Thousand |
| Financing Cash Flow | -23 Thousand | -23 Thousand | -59.33 | -246 Thousand | -61.12 | -130.28 Thousand |
| Debt repayment | - | - | - | -290 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 102 Thousand | - | - | 44 Thousand | - | 22.07 Thousand |
| Other Financing Activities | -23 Thousand | -23 Thousand | -59.33 | 44.00 | -61.12 | -62.23 |
| Accounts receivables | 174 Thousand | 174 Thousand | 747.50 | 1.04 Million | 741.14 | -461.4 Thousand |
| Accounts payables | -1.95 Million | - | - | -4.27 Million | - | 15 Thousand |
| Inventory | - | - | - | - | - | 1.00 |
| Other working capital | 306 Thousand | 306 Thousand | 205.81 | 13.76 Million | 195.00 | -1.26 Million |
| Cash at beginning of period | 81.17 Million | - | -0.86 | 79.01 Million | -0.32 | 79.15 Million |
| Cash at end of period | 110.17 Million | 2.08 Million | 10.71 Thousand | 106 Million | 10.79 Thousand | 81.17 Million |
| Capital Expenditure | -218 Thousand | -218 Thousand | -7.38 | -294 Thousand | -11.32 | -285.67 Thousand |
| Effect of forex changes on cash | -45 Thousand | -45 Thousand | -1287.94 | 18 Thousand | -1251.38 | 1267.49 |
| Net cash flow / Change in cash | 28.99 Million | 2.08 Million | 10.71 Thousand | 26.99 Million | 10.79 Thousand | 2.02 Million |
| Free Cash Flow | -4.2 Million | -4.2 Million | -8779.25 | -48.22 Million | -9211.50 | -31.37 Million |
MKGP
EORBF
ENGQF
COTQF
RNC
600691